Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 23971133)

1.

[IV. Molecular targeting therapy for head and neck cancer].

Fujii M.

Gan To Kagaku Ryoho. 2013 Jul;40(7):867-70. Japanese. No abstract available.

PMID:
23971133
2.

[II. Molecular targeting therapy for head and neck cancer].

Tahara M.

Gan To Kagaku Ryoho. 2012 Jul;39(7):1055-60. Review. Japanese. No abstract available.

PMID:
22896873
3.

[Clinical trials of combinations of molecular targeting drugs for head and neck cancer].

Fujii M.

Gan To Kagaku Ryoho. 2008 Jul;35(7):1122-5. Japanese. No abstract available.

PMID:
18686361
4.

Progress and perspectives in chemoprevention of head and neck cancer.

Wirth LJ, Haddad RI, Posner MR.

Expert Rev Anticancer Ther. 2003 Jun;3(3):339-55. Review.

PMID:
12820777
5.

Why has so much chemotherapy done so little in head and neck cancer?

Taylor SG 4th.

J Clin Oncol. 1987 Jan;5(1):1-3. No abstract available.

PMID:
3543232
6.

Induction chemotherapy in head and neck cancer.

Hitt R.

Ann Oncol. 2006 Sep;17 Suppl 10:x42-4. Review. No abstract available.

7.

Induction chemotherapy for advanced head and neck cancer.

Hong WK.

Head Neck Surg. 1988 Jan-Feb;10(3):147-9. No abstract available.

PMID:
3069808
8.

Does concurrent postoperative radiotherapy and chemotherapy in head and neck cancer improve patient outcome?

Yom SS, Rosenthal DI.

Nat Clin Pract Oncol. 2004 Nov;1(1):14-5. No abstract available.

PMID:
16264790
9.

Second-line chemotherapy in head and neck cancer: what should we expect?

Büntzel J, Micke O.

Expert Rev Anticancer Ther. 2009 Mar;9(3):269-73. doi: 10.1586/14737140.9.3.269. No abstract available.

PMID:
19275504
10.

Targeting epidermal growth factor receptor in head and neck cancer: lessons learned from cetuximab.

Moon C, Chae YK, Lee J.

Exp Biol Med (Maywood). 2010 Aug;235(8):907-20. doi: 10.1258/ebm.2009.009181. Epub 2010 Jun 18. Review.

PMID:
20562132
11.

Combined modality therapy of head and neck cancer.

Stupp R, Weichselbaum RR, Vokes EE.

Semin Oncol. 1994 Jun;21(3):349-58. Review. No abstract available.

PMID:
8209266
12.

Redefining the role of induction chemotherapy in head and neck cancer.

Adelstein DJ.

J Clin Oncol. 2008 Jul 1;26(19):3117-9. doi: 10.1200/JCO.2007.15.2256. Epub 2008 May 12. No abstract available.

13.

Adjuvant chemotherapy in head and neck cancer.

Stell PM.

Clin Otolaryngol Allied Sci. 1990 Jun;15(3):193-5. No abstract available.

PMID:
2144220
14.

[Use of docetaxel in treatment of squamous-cell carcinoma of head and neck].

Subramanian S, Kanagavel D, Petenko NN, Orlova KV, Samoĭlenko IV, Demidov LV.

Vopr Onkol. 2011;57(4):421-6. Review. Russian. No abstract available.

PMID:
22191228
15.

Integration of chemotherapy into the definitive management of squamous cell head and neck cancer.

Adelstein DJ.

Curr Oncol Rep. 1999;1(2):97-8. No abstract available.

PMID:
11122804
16.

[Limitations in intra-arterial infusions of chemotherapy for head and neck cancer].

Yoshizaki T.

Gan To Kagaku Ryoho. 2008 Jul;35(7):1106-9. No abstract available.

PMID:
18686358
17.

Vinblastine, methotrexate, bleomycin, in the management of head and neck cancer.

Vanhaelen C, Bertrand M, De Jager R, Kenis Y.

Eur J Cancer. 1979 Nov;15(11):1315-8. No abstract available.

PMID:
93540
18.

Molecular-targeted therapies in head and neck cancer.

Rao SD, Fury MG, Pfister DG.

Semin Radiat Oncol. 2012 Jul;22(3):207-13. doi: 10.1016/j.semradonc.2012.03.005.

PMID:
22687945
19.

Targeted therapy in head and neck cancer.

Bianchini C, Ciorba A, Pelucchi S, Piva R, Pastore A.

Tumori. 2011 Mar-Apr;97(2):137-41. doi: 10.1700/667.7773. Review.

20.

Molecular targeted therapies in the management of head and neck squamous cell carcinoma: recent developments and perspectives.

Bozec A, Peyrade F, Milano G.

Anticancer Agents Med Chem. 2013 Mar;13(3):389-402. Review.

PMID:
23092267
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk